207 related articles for article (PubMed ID: 25669902)
1. Poly-arginine and arginine-rich peptides are neuroprotective in stroke models.
Meloni BP; Brookes LM; Clark VW; Cross JL; Edwards AB; Anderton RS; Hopkins RM; Hoffmann K; Knuckey NW
J Cereb Blood Flow Metab; 2015 Jun; 35(6):993-1004. PubMed ID: 25669902
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective peptides fused to arginine-rich cell penetrating peptides: Neuroprotective mechanism likely mediated by peptide endocytic properties.
Meloni BP; Milani D; Edwards AB; Anderton RS; O'Hare Doig RL; Fitzgerald M; Palmer TN; Knuckey NW
Pharmacol Ther; 2015 Sep; 153():36-54. PubMed ID: 26048328
[TBL] [Abstract][Full Text] [Related]
3. Characterisation of neuroprotective efficacy of modified poly-arginine-9 (R9) peptides using a neuronal glutamic acid excitotoxicity model.
Edwards AB; Anderton RS; Knuckey NW; Meloni BP
Mol Cell Biochem; 2017 Feb; 426(1-2):75-85. PubMed ID: 27844251
[TBL] [Abstract][Full Text] [Related]
4. The Neuroprotective Peptide Poly-Arginine-12 (R12) Reduces Cell Surface Levels of NMDA NR2B Receptor Subunit in Cortical Neurons; Investigation into the Involvement of Endocytic Mechanisms.
MacDougall G; Anderton RS; Edwards AB; Knuckey NW; Meloni BP
J Mol Neurosci; 2017 Feb; 61(2):235-246. PubMed ID: 27866326
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the Neuroprotective Effects of Arginine-Rich Protamine Peptides, Poly-Arginine Peptides (R12-Cyclic, R22) and Arginine-Tryptophan-Containing Peptides Following In Vitro Excitotoxicity and/or Permanent Middle Cerebral Artery Occlusion in Rats.
Meloni BP; Milani D; Cross JL; Clark VW; Edwards AB; Anderton RS; Blacker DJ; Knuckey NW
Neuromolecular Med; 2017 Sep; 19(2-3):271-285. PubMed ID: 28523591
[TBL] [Abstract][Full Text] [Related]
6. In vitro cellular uptake and neuroprotective efficacy of poly-arginine-18 (R18) and poly-ornithine-18 (O18) peptides: critical role of arginine guanidinium head groups for neuroprotection.
MacDougall G; Anderton RS; Ouliel E; Gao J; Redmond SL; Knuckey NW; Meloni BP
Mol Cell Biochem; 2020 Jan; 464(1-2):27-38. PubMed ID: 31679100
[TBL] [Abstract][Full Text] [Related]
7. The neuroprotective efficacy of cell-penetrating peptides TAT, penetratin, Arg-9, and Pep-1 in glutamic acid, kainic acid, and in vitro ischemia injury models using primary cortical neuronal cultures.
Meloni BP; Craig AJ; Milech N; Hopkins RM; Watt PM; Knuckey NW
Cell Mol Neurobiol; 2014 Mar; 34(2):173-81. PubMed ID: 24213248
[TBL] [Abstract][Full Text] [Related]
8. Poly-arginine R18 and R18D (D-enantiomer) peptides reduce infarct volume and improves behavioural outcomes following perinatal hypoxic-ischaemic encephalopathy in the P7 rat.
Edwards AB; Cross JL; Anderton RS; Knuckey NW; Meloni BP
Mol Brain; 2018 Feb; 11(1):8. PubMed ID: 29426351
[TBL] [Abstract][Full Text] [Related]
9. Poly-arginine peptides reduce infarct volume in a permanent middle cerebral artery rat stroke model.
Milani D; Clark VW; Cross JL; Anderton RS; Knuckey NW; Meloni BP
BMC Neurosci; 2016 May; 17(1):19. PubMed ID: 27142074
[TBL] [Abstract][Full Text] [Related]
10. Proteomic analysis of cortical neuronal cultures treated with poly-arginine peptide-18 (R18) and exposed to glutamic acid excitotoxicity.
MacDougall G; Anderton RS; Mastaglia FL; Knuckey NW; Meloni BP
Mol Brain; 2019 Jul; 12(1):66. PubMed ID: 31315638
[TBL] [Abstract][Full Text] [Related]
11. Comparison of neuroprotective efficacy of poly-arginine R18 and R18D (D-enantiomer) peptides following permanent middle cerebral artery occlusion in the Wistar rat and in vitro toxicity studies.
Milani D; Bakeberg MC; Cross JL; Clark VW; Anderton RS; Blacker DJ; Knuckey NW; Meloni BP
PLoS One; 2018; 13(3):e0193884. PubMed ID: 29513757
[TBL] [Abstract][Full Text] [Related]
12. Poly-arginine-18 (R18) Confers Neuroprotection through Glutamate Receptor Modulation, Intracellular Calcium Reduction, and Preservation of Mitochondrial Function.
MacDougall G; Anderton RS; Trimble A; Mastaglia FL; Knuckey NW; Meloni BP
Molecules; 2020 Jun; 25(13):. PubMed ID: 32610439
[TBL] [Abstract][Full Text] [Related]
13. AP-1 inhibitory peptides are neuroprotective following acute glutamate excitotoxicity in primary cortical neuronal cultures.
Meade AJ; Meloni BP; Cross J; Bakker AJ; Fear MW; Mastaglia FL; Watt PM; Knuckey NW
J Neurochem; 2010 Jan; 112(1):258-70. PubMed ID: 19878434
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effects of the survival promoting peptide Y-P30.
Schneeberg J; Riek-Burchardt M; Braun H; Landgraf P; Kreutz MR; Reymann KG
Eur J Pharmacol; 2009 Aug; 616(1-3):81-5. PubMed ID: 19490911
[TBL] [Abstract][Full Text] [Related]
15. AP-1 inhibitory peptides attenuate in vitro cortical neuronal cell death induced by kainic acid.
Meade AJ; Meloni BP; Mastaglia FL; Watt PM; Knuckey NW
Brain Res; 2010 Nov; 1360():8-16. PubMed ID: 20833150
[TBL] [Abstract][Full Text] [Related]
16. Excitotoxicity-induced endocytosis mediates neuroprotection by TAT-peptide-linked JNK inhibitor.
Vaslin A; Naegele-Tollardo S; Puyal J; Clarke PG
J Neurochem; 2011 Dec; 119(6):1243-52. PubMed ID: 22004371
[TBL] [Abstract][Full Text] [Related]
17. Comparative Assessment of the Proteolytic Stability and Impact of Poly-Arginine Peptides R18 and R18D on Infarct Growth and Penumbral Tissue Preservation Following Middle Cerebral Artery Occlusion in the Sprague Dawley Rat.
Milani D; Clark VW; Feindel KW; Blacker DJ; Bynevelt M; Edwards AB; Anderton RS; Knuckey NW; Meloni BP
Neurochem Res; 2021 May; 46(5):1166-1176. PubMed ID: 33523394
[TBL] [Abstract][Full Text] [Related]
18. Assessment of recombinant tissue plasminogen activator (rtPA) toxicity in cultured neural cells and subsequent treatment with poly-arginine peptide R18D.
Kenna JE; Anderton RS; Knuckey NW; Meloni BP
Neurochem Res; 2020 May; 45(5):1215-1229. PubMed ID: 32140956
[TBL] [Abstract][Full Text] [Related]
19. Glutamate preconditioning prevents neuronal death induced by combined oxygen-glucose deprivation in cultured cortical neurons.
Lin CH; Chen PS; Gean PW
Eur J Pharmacol; 2008 Jul; 589(1-3):85-93. PubMed ID: 18589412
[TBL] [Abstract][Full Text] [Related]
20. Assessment of R18, COG1410, and APP96-110 in Excitotoxicity and Traumatic Brain Injury.
Chiu LS; Anderton RS; Cross JL; Clark VW; Edwards AB; Knuckey NW; Meloni BP
Transl Neurosci; 2017; 8():147-157. PubMed ID: 29177102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
